Condition

Inflammatory Myositis clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Inflammatory Myositis clinical trials that are recruiting, at sites in 2 countries (most in France (2), China (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Inflammatory Myositis clinical trials

StudyPhaseWhereStatusRegistered
BCT301 CAR-iT cell therapy for hard-to-treat autoimmune diseases Early Phase 1 Beijing Recruiting Dec 24, 2025
Investigating the role of platelets in autoimmune diseases — Strasbourg, France Recruiting Sep 19, 2024
Follow-up of patients with inflammatory myopathies and a biobank — Paris and 1 other locations Recruiting Jul 12, 2022

All recruiting trials (3)

Related topics

ANCA Associated VasculitisAntiphospholipid SyndromeRheumatoid ArthritisSjogren SyndromeSystemic Lupus ErythematosusSystemic Sclerosis (SSc)

Quick answers

How many Inflammatory Myositis clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in France (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.